Navigation Links
Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,,and Capecitabine

and granted priority review of, these data as part of the New Drug Application for ixabepilone. The target action date is in late October. The proposed indications for ixabepilone are as a monotherapy to treat patients with metastatic or locally advanced breast cancer after failure of an anthracycline, a taxane, and capecitabine and in combination with capecitabine to treat patients with metastatic or locally advanced breast cancer after failure of an anthracycline and a taxane. The company also plans to submit these data as part of a registrational dossier in the European Union, and other countries this year.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995 regarding product development. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Among other risks, there can be no guarantee that the application submitted to the FDA will be approved, that an application will be submitted or approved in any other country, or, if approved, that the product will be commercially successful. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb's business, particularly those identified in the cautionary factors discussion in Bristol-Myers Squibb's Annual Report on Form 10-K for the year ended December 31, 2006 and in our Quarterly Reports on Form 10-Q. Bristol-Myers Squibb undertakes no obligation to publicly update any forward-looking statement, whether as a resu
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:9/18/2014)... days before the government of Sierra Leone ... Ebola, World Vision will begin a massive delivery of 200 ... McKesson, the largest healthcare services company in ... Medical-Surgical donated four million pairs of latex gloves – enough ... needs for the next five months* – to ...
(Date:9/18/2014)... HELSINKI, Finland , September 18, 2014 ... congresses   Nexstim (the "Company"), a medical technology ... of a new NBS system, NBS 5, for noninvasive presurgical ... at two international neurosurgery congresses during the month of October ... other in the USA . ...
(Date:9/17/2014)... NEW YORK , Sept. 17, 2014 ... Summary GlobalData,s new report, "BRIC Biopsy ... on the BRIC Biopsy Devices market. The report provides ... and average prices (in US dollars) within market segments ... Needles (Core Needles, Fine Aspiration Needles (Disposable and Reusable ...
Breaking Medicine Technology:World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 2World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 3World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 4Nexstim Launches Next Generation NBS 5 System 2Nexstim Launches Next Generation NBS 5 System 3Nexstim Launches Next Generation NBS 5 System 4Nexstim Launches Next Generation NBS 5 System 5BRIC Biopsy Devices Market Outlook to 2020 2BRIC Biopsy Devices Market Outlook to 2020 3
... (OTC: HEWA) a leading VIPPS accredited retail mail-order pharmacy, ... ended September 30, 2011. In the ... increased $1,567,764 to $2,783,240, up 129% compared to the ... strength in its prescription business.  Prescriptions filled increased from ...
... Nov. 17, 2011 Cohera Medical, a rapidly growing ... selling its lead product, TissuGlu® Surgical Adhesive, to hospitals ... regional launch will document and highlight the advantages of ... expansion throughout Germany and to additional European markets in ...
Cached Medicine Technology:HealthWarehouse.com Reports 129% Quarter-Over-Quarter Revenue Growth in the Third Quarter 2011 2Cohera Medical Commercializes TissuGlu® Surgical Adhesive in Germany 2Cohera Medical Commercializes TissuGlu® Surgical Adhesive in Germany 3
(Date:9/18/2014)... and CAMBRIDGE, Massachusetts, U.S.A., September 18, 2014 -- ... providing sequencing service to Denmark-based DLF-Trifolium and the ... Aarhus University in an effort to develop a ... employing genomic selection (GS) methods. , GS is ... in contrast to the traditional QTL-based selection, uses ...
(Date:9/18/2014)... September 18, 2014 CRDF Global ... first ever digital edition – rich with videos, ... of how CRDF Global empowers scientists and innovators ... of government, corporate, foundation and individual supporters, CRDF ... innovators in research, training and entrepreneurship. , The ...
(Date:9/18/2014)... PA (PRWEB) September 18, 2014 Research ... from Allegheny Health Network has documented improved ... both surgical removal of the tumors along with stereotactic ... meeting of ASTRO (American Society for Radiation ... (SRS) uses numerous precisely focused radiation beams to treat ...
(Date:9/18/2014)... September 18, 2014 Phela Health and ... HABIT™ Program in South Africa. HABIT™ is ... Wellness, and distributed in South Africa by Bestflex. , ... program, which has been tailored to address issues that ... on behavior modification and chronic disease prevention. This solution ...
(Date:9/18/2014)... Denham Springs, LA (PRWEB) September 18, 2014 This ... got a kiss from Roy at the kissing booth during ... L. “Bo” Bryant Animal Shelter. “I have loved animals my ... family with most of those animals being strays who needed a ... more animals since I can’t take them all home!” , The ...
Breaking Medicine News(10 mins):Health News:BGI Tech, DLF-Trifolium A/S, and Aarhus University applying genomic selection methods 2Health News:CRDF Global Launches Media-Rich Digital Edition of Annual Report, Tells Story of Empowering Scientists and Innovators around the World in 2013 2Health News:Allegheny Health Network Study Shows Improved Survival in Patients with Metastatic Brain Cancer Who Undergo Surgical Excision Combined with Stereotactic Radiosurgery 2Health News:Allegheny Health Network Study Shows Improved Survival in Patients with Metastatic Brain Cancer Who Undergo Surgical Excision Combined with Stereotactic Radiosurgery 3Health News:Narconon New Life Retreat Supports Local Animal Shelter At Recent Fundraiser 2
... , , ... , , ATLANTA, Sept. 11 Atlanta-based indoor ... as the only laboratory in the United States to perform office ... is the oldest and most respected eco-label in the world. ...
... Sept. 11 Corgenix Medical Corporation (OTC Bulletin Board: CONX), a ... conference call on Friday, September 25, 2009, at 4:00 PM EDT ... year ended June 30, 2009, and the status of the Company,s ... Corgenix invites all those interested in hearing management,s discussion of the ...
... alone doesn,t measure severity of cases, researchers say , FRIDAY, ... value of hospital report cards and national rankings when it ... Health System in Chicago say the mortality index, a statistic ... a given area of medical care, may be inflated -- ...
... infection tends to strike young adults, expert says , ... has been focused on getting vaccinated for both the ... nationwide effort has been launched to highlight the need ... sometimes deadly infection that tends to strike teenagers and ...
... ... at the lowest prices possible. To maintain high quality standards and ensure consumer trust, ... of product safety and efficacy. , ... Fargo, ND (Vocus) September 11, 2009 -- Last month ConsumerLab.com (CL), ...
... , , , , ... of Celebratory Events , , VALHALLA, N.Y., ... the advanced care pediatric facility serving New York,s Hudson Valley region ... September and will commemorate the milestone with a year-long series of ...
Cached Medicine News:Health News:Air Quality Sciences Achieves Re-Accreditation as the US Indoor Air Quality Testing Partner for Europe's Coveted Blue Angel Program 2Health News:Air Quality Sciences Achieves Re-Accreditation as the US Indoor Air Quality Testing Partner for Europe's Coveted Blue Angel Program 3Health News:Report Cards for Hospitals May Be Misleading 2Health News:Actress Helps Promote New Campaign for Meningitis Vaccine 2Health News:Actress Helps Promote New Campaign for Meningitis Vaccine 3Health News:Swanson Health Products' Vitamin E and Acai Dietary Supplements Pass Quality Control Tests Conducted by ConsumerLab.com 2Health News:Celebrating Five Years of Advanced Care Excellence: Maria Fareri Children's Hospital at Westchester Medical Center Reaches a Milestone 2Health News:Celebrating Five Years of Advanced Care Excellence: Maria Fareri Children's Hospital at Westchester Medical Center Reaches a Milestone 3
... Loading Units With Titanium Staples ... TA™ (Single Use Reloadable Stapler ... Auto Suture™ PREMIUM MULTIFIRE TA™ ... gynecological, pediatric and thoracic surgical ...
Single Use Reloadable Stapler with Titanium Staples., ,The Auto Suture™ PREMIUM MULTIFIRE TA™ stapler has applications in abdominal, gynecological, pediatric and thoracic surgical proced...
... Single Use reloadable linear stapler with ... PI™ disposable stapler is designed for use ... healthy internal tissues. The instrument places a ... when using the 30 VASCULAR cartridges) of ...
... Use Loading Units With Titanium Staples for ... Staplers With Titanium Staples)., ,The Auto ... use surgical staplers with MULTIFIRE GIA™ 60 ... the Auto Suture™ MULTIFIRE SGIA™ 60 knifeless ...
Medicine Products: